CVS Health stock: buy or sell?
Updated on:
November 19th, 2019
3
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail\u002FLTC segments.
Should I buy CVS Health stock?
Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading strategy that matches with your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.None of our preferred buy setups matches with CVS Health stock situation right now, therefore this is not a suitable entry point.
| Buy setup | Elegible |
|---|---|
| New all-time high | No |
| New 52 week high | No |
| Price crossing up 200d MA | No |
| 100d MA crossing up 200d MA | No |
Is CVS Health stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.
At Stocks2.com, we collected 15 ratings published for CVS stock in the last month. The general sentiment of these ratings is bullish for CVS stock, with 9 positive ratings.| Date | Analyst / Broker | Previous rating | Current rating |
| 2019-9-27 | Royal Bank of Canada | n/a | Outperform |
| 2019-9-26 | Morgan Stanley | n/a | Overweight |
| 2019-9-12 | Deutsche Bank | n/a | Buy |
| 2019-9-12 | Bank of America | n/a | Buy |
| 2019-8-8 | Citigroup | n/a | Buy |
| 2019-8-27 | Cowen | n/a | Outperform |
| 2019-5-2 | UBS Group | Buy | Sell |
| 2019-5-2 | UBS Group | Sell | Sell |
| 2019-5-2 | Citigroup | n/a | Buy |
| 2019-4-29 | Morgan Stanley | Overweight | Overweight |
| 2019-4-29 | Credit Suisse Group | Outperform | Neutral |
| 2019-4-18 | Raymond James | Strong-Buy | Strong-Buy |
| 2019-4-15 | Oppenheimer | Outperform | Market Perform |
| 2019-4-10 | SunTrust Banks | n/a | n/a |
| 2019-4-10 | Bank of America | n/a | Buy |
CVS Health stock analysis
Daily outlook
CVS Health shares stayed constant 0.33% to $75.35 today.
CVS Health ended today at $75.35 and stayed stable a slightly fine 0.33%. Since SMA100d and SMA200d crossed up on October/14, CVS price climbed $12.88 per share (20.62%). CVS shows a strong short term uptrend with several rising tops and rising bottoms. Since its last bottom on November 12th, CVS climbed unceasignly breaking out above its last top at 72.98.
Weekly outlook
CVS Health shares raised 1.43% this week, ending at $75.35. This week was the 4th green week in a row. Early November CVS boosted an extraordinary 7.22% in just one week.
Price pattern shows an uptrend with two rising tops and bottoms, and now finally trading above the $64.76 resistance. Since SMA20d and SMA40w crossed up early October, CVS price climbed $13.58 per share (21.98%). Since price and SMA40w lines crossed up by mid August, CVS climbed $16.51 (28.06%).
CVS Health stock price history
CVS Health stock historical price chart
CVS stock reached 52-week highs on November at $78.95, and all-time highs 2015-07-29 with a price of 101.95.
CVS Health stock price target is $74.50
How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we found 12 price forecasts for CVS Health stock:| Date | Analyst / Broker | Action | Previous target | Current target | Diff |
| 2019-9-26 | Morgan Stanley | Raises Target | $74.00 | $77.00 | 4.1% |
| 2019-9-12 | Deutsche Bank | Initiates | n/a | $91.00 | - |
| 2019-9-12 | Bank of America | Raises Target | $72.00 | $75.00 | 4.2% |
| 2019-8-8 | Citigroup | Reiterates | $68.00 | $72.00 | 5.9% |
| 2019-8-27 | Cowen | Reiterates | $69.00 | $76.00 | 10.1% |
| 2019-5-2 | UBS Group | Raises Target | $67.00 | $74.00 | 10.4% |
| 2019-5-2 | UBS Group | Lowers Target | $74.00 | $67.00 | -9.5% |
| 2019-5-2 | Citigroup | Set Price Target | n/a | $74.00 | - |
| 2019-4-29 | Morgan Stanley | Lowers Target | $92.00 | $74.00 | -19.6% |
| 2019-4-18 | Raymond James | Lowers Target | $90.00 | $75.00 | -16.7% |
| 2019-4-10 | SunTrust Banks | Lowers Target | $85.00 | $65.00 | -23.5% |
| 2019-4-10 | Bank of America | Lowers Target | $82.00 | $74.00 | -9.8% |
| (in average) | $77.30 | $74.50 | -4.0% |
Financials and fundamental analysis
Earnings date and Earnings per Share
CVS Health reported slightly good results for 2018-Q4 on February. CVS Health gained Earnings per Share (EPS) by 3.40%, beating experts of $2.07. CVS Health posted $2.14.| Quarter | Reporting date | Estimated EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| 2017-Q2 | - | n/a | 1.07 | n/a |
| 2017-Q3 | 2017-11-06 | 1.49 | 1.5 | 0.7% |
| 2017-Q4 | 2018-02-08 | 1.88 | 1.92 | 2.1% |
| 2018-Q1 | 2018-05-02 | 1.39 | 1.48 | 6.5% |
| 2018-Q2 | 2018-08-08 | 1.61 | 1.69 | 5.0% |
| 2018-Q3 | 2018-11-06 | 1.71 | 1.73 | 1.2% |
| 2018-Q4 | 2019-02-20 | 2.07 | 2.14 | 3.4% |
| 2019-Q1 | - | n/a | n/a | n/a |
| 2019-Q2 | - | n/a | n/a | n/a |
| 2019-Q3 | - | n/a | n/a | n/a |
Annual financial results
Compared to 2017, last anual turnover report draw a nice increase of 5.30% to $194,579.00 M USD. However, its profit margin (compared to sales) declined to -0.31%, that is $-594.00 million.| Year | Sales | YoY | Income/(margin) | YoY |
|---|---|---|---|---|
| 2013 | $126,760 M | - | $4,600 M3.6% | - |
| 2014 | $139,367 M | 9.95% | $4,644 M3.3% | 0.96% |
| 2015 | $153,290 M | 9.99% | $5,237 M3.4% | 12.77% |
| 2016 | $177,526 M | 15.81% | $5,317 M3.0% | 1.53% |
| 2017 | $184,786 M | 4.09% | $6,622 M3.6% | 24.54% |
| 2018 | $194,579 M | 5.30% | $-594.00 M-0.3% | -108.97% |
Quarterly financial results
CVS Health posted $54,909.00 M in sales for 2018-Q4, a 16.16% up compared to previous quarter. Reported quarter income marked $-419.00 million with a profit margin of -0.76%. Profit margin decreased a -3.70% compared to previous quarter when profit margin was 2.94%. When comparing revenues to same quarter last year, CVS Health sales marked an astounding gain and skyrocketed a 13.48%. Looking back to recent quarterly results, CVS Health posted 3 positive quarters in a row.| Quarter | Sales1 | QoQ2 | Income1/(margin) | QoQ2 |
|---|---|---|---|---|
| 2017-Q2 | $45,690 M | - | $1,090.00 M2.4% | - |
| 2017-Q3 | $46,181 M | 1.07% | $1,285.00 M2.8% | 17.89% |
| 2017-Q4 | $48,385 M | 4.77% | $3,287.00 M6.8% | 155.80% |
| 2018-Q1 | $45,693 M | -5.56% | $998.00 M2.2% | -69.64% |
| 2018-Q2 | $46,708 M | 2.22% | $-2,563.00 M-5.5% | -356.81% |
| 2018-Q3 | $47,269 M | 1.20% | $1,390.00 M2.9% | -154.23% |
| 2018-Q4 | $54,909 M | 16.16% | $-419.00 M-0.8% | -130.14% |
| 2019-Q1 | $61,646 M | 12.27% | $1,421.00 M2.3% | -439.14% |
CVS Health ownership
When you are planning to invest in a stock, it's worth to overview its ownership structure.CVS Health shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.24% of all shares.
Bearish positions for CVS stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related stocks:
| CVS | PETS | WBA | |
|---|---|---|---|
| Market cap | $98.0 B | $457.3 M | $55.3 B |
| Total shares | 1,300.0 M | 20.2 M | 892.5 M |
| Float shares | 1,300.0 M | 17.2 M | 743.2 M |
| - Institutional holdings (%) | 83.8% | 104.8% | 66.4% |
| - Insider holdings (%) | 0.2% | 3.8% | 16.1% |
| Shares in short selling | 0.0% | 0.0% | 0.0% |
CVS Health summary
| Tuesday, November 19th, 2019 | |
|---|---|
| Open | $75.28 |
| Close | $75.35 |
| Day range | $74.46 - $75.47 |
| Previous close | $75.10 |
| Session gain | 0.33% |
| Average true range | $1.41 |
| 50d mov avg | $65.56 |
| 100d mov avg | $61.55 |
| 200d mov avg | $58.10 |
| Daily pattern | lb03c |
| Weekly pattern | lb02c |
CVS Health performance
To measure stock performance is always good to compare with competitors or related stocks. For CVS Health, the benchmark is made against PetMed Express and Walgreens Boots Alliance.| Stock | 3m | 6m | 12m |
|---|---|---|---|
| CVSCVS Health | 26.02% | 44.35% | 3.65% |
| PETSPetMed Express | 48.36% | 27.86% | -4.02% |
| WBAWalgreens Boots A... | 26.51% | 21.64% | -20.93% |
CVS Health competitors
Creating a list of competitors for CVS Health it's not an easy task. We selected 2 public companies that are related to and can be considered as competitors of CVS Health:Latest CVS Health stock news
- InvestorPlaceHere’s The Not-So-Crazy Speculative Case for CVS Health StockJuly 24, 2019
- InvestorPlaceIf Everything is Going Wrong for CVS Health Stock, is That a Buy Signal?July 10, 2019
- InvestorPlace3 Big Stock Charts for Wednesday: CVS Health, Pfizer and WeyerhaeuserJuly 3, 2019
- InvestorPlaceCVS Health Stock Has Cannibalized ItselfJune 21, 2019
- Seeking Alpha3 Reasons CVS Health's Future Looks Bright Despite Current ChallengesJune 13, 2019